JP4848315B2 - Fatigue food and its manufacturing method - Google Patents

Fatigue food and its manufacturing method Download PDF

Info

Publication number
JP4848315B2
JP4848315B2 JP2007151072A JP2007151072A JP4848315B2 JP 4848315 B2 JP4848315 B2 JP 4848315B2 JP 2007151072 A JP2007151072 A JP 2007151072A JP 2007151072 A JP2007151072 A JP 2007151072A JP 4848315 B2 JP4848315 B2 JP 4848315B2
Authority
JP
Japan
Prior art keywords
cyanidin
fatigue
eyes
food
glycoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2007151072A
Other languages
Japanese (ja)
Other versions
JP2008301752A5 (en
JP2008301752A (en
Inventor
隆則 吉田
好男 北田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Nippon Shinyaku Co Ltd
Original Assignee
Pola Chemical Industries Inc
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc, Nippon Shinyaku Co Ltd filed Critical Pola Chemical Industries Inc
Priority to JP2007151072A priority Critical patent/JP4848315B2/en
Publication of JP2008301752A publication Critical patent/JP2008301752A/en
Publication of JP2008301752A5 publication Critical patent/JP2008301752A5/ja
Application granted granted Critical
Publication of JP4848315B2 publication Critical patent/JP4848315B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

本発明は、食品に関し、更に詳細には、疲れ目の予防又は改善に好適な食品に関する。又、本発明は該食品の製造法に関する。   The present invention relates to a food, and more particularly, to a food suitable for preventing or improving fatigue eyes. The present invention also relates to a method for producing the food.

現代社会は車の運転やVDT(Visual Display Terminal)作業、パソコンやテレビなど目を使い続ける時代である。加えて、睡眠時間が極端に短くなり、起きている時間が長くなるなどライフスタイル自体も目に対して負担を強いるものになっている。環境の面では、大気汚染に由来するオゾンホールの拡大が、紫外線の地上到達量を激増させ、紫外線による目の損傷も増えていると言える。斯くの如くに、現代社会は、目にとって負担の極めて多い環境と言え、それに伴い、疲れ目や眼精疲労などの目のトラブルに悩む人が急増している。この為、疲れ目等の目のトラブル症状改善に有効な医薬品、食品などQOL(Quality Of Life)の向上が期待される商品が望まれている。   The modern society is an era in which people continue to use their eyes such as driving a car, VDT (Visual Display Terminal) work, personal computers and televisions. In addition, the lifestyle itself imposes a burden on the eyes, such as an extremely short sleeping time and a long waking time. In terms of the environment, it can be said that the expansion of the ozone hole due to air pollution has dramatically increased the amount of ultraviolet rays reaching the ground, and the damage to the eyes due to ultraviolet rays has also increased. In this way, the modern society can be said to be an extremely burdensome environment for the eyes, and accordingly, the number of people who suffer from eye troubles such as tired eyes and eyestrain is increasing rapidly. Therefore, there is a demand for products that are expected to improve QOL (Quality Of Life), such as pharmaceuticals and foods that are effective in improving symptoms of eye problems such as fatigue.

一般的には、疲れ目と眼精疲労とは区別されて認識されたり、使用されたりはしていないが、専門の眼科の定義では、この二者は明確に区別されている。すなわち、疲れ目は生理的な疲労であり、眼精疲労は病的な疲労の範疇に入る。言い換えれば、疲れ目は休息によって回復し、眼精疲労は休息によってもその症状が改善しないものと言うことができる(非特許文献1)。しかしながら精神的な疲労の度合いで疲れ目が眼精疲労に、また眼精疲労が単なる疲れ目になり得ることもあるので、実態としては、このような定義、区別もあいまいと言わざるを得ない。疲れ目の中には、休息によって回復するものの、その回復に時間を要し、さりとて、その予後が良いため眼精疲労とは言い難いものがあるし、眼精疲労においては、初期症状は極めて重篤であり、病的であることには間違いがないが、その予後は極めて良く、回復に時間をそう長くは要しないものも存する。   In general, tired eyes and eye strain are not recognized and used separately, but in the definition of specialized ophthalmology, the two are clearly distinguished. That is, fatigue eyes are physiological fatigue, and eyestrain falls into the category of pathological fatigue. In other words, it can be said that fatigued eyes are recovered by rest, and eyestrain does not improve the symptoms even by resting (Non-patent Document 1). However, depending on the degree of mental fatigue, eyestrain may become eyestrain, and eyestrain may just be eyestrain. Therefore, in reality, such a definition and distinction must be vague. . Some tired eyes recover by rest, but it takes time to recover, and the prognosis is so good that it is hard to say eye strain. There is no doubt that it is serious and morbid, but some have a very good prognosis and do not take so long to recover.

病理学的には、眼精疲労の原因は定義付けされており、視器要因、内環境要因・心的要因、外環境要因の3種類に大別されている(例えば、非特許文献2を参照)。中でも、外環境要因は非常に大きなウエイトを占めることが推測され、中でも光刺激要素(有害光線)は角膜に直接的なダメージを与えるため、紫外線が眼精疲労の重要なファクターと考えられている。紫外線によって角膜に障害を引き起こすメカニズムは、現在もまだ完全には分かっていない(例えば、特許文献1を参照)が、特にUV−B波が原因(非特許文献3)となって活性酸素種が脂質やタンパク質、DNAなどと反応することによってダメージを与えているのではないかと考えられている(例えば、非特許文献4を参照)。一方、疲れ目の原因は現在定義付けがされておらず、又、事実として、原因が不明な部分も存する。その主たる症状としては目が「ショボショボする、チカチカする、ズキズキする、ゴロゴロする、ヒリヒリする、ぼんやりする」などが挙げられる。いわば、この様な症状を呈する、目のトラブルの総称が「疲れ目」に分類されており、一種の症候群ともいえる。   Pathologically, the causes of eye strain are defined and roughly classified into three types: visual factors, internal environmental factors / mental factors, and external environmental factors (for example, Non-Patent Document 2). reference). In particular, it is speculated that external environmental factors occupy a very large weight, and light stimulating elements (harmful rays) directly damage the cornea, so ultraviolet rays are considered to be an important factor in eye strain. . The mechanism that causes damage to the cornea due to ultraviolet rays is still not completely understood (see, for example, Patent Document 1), but in particular, reactive oxygen species are caused by UV-B waves (Non-Patent Document 3). It is considered that damage is caused by reacting with lipids, proteins, DNA, etc. (see, for example, Non-Patent Document 4). On the other hand, the cause of tired eyes is not currently defined, and there is a fact that the cause is unknown. The main symptoms include eyes that are “shobo-shobo, flickering, throbbing, roaring, tingling, blurred”. In other words, the general term for eye troubles that exhibit such symptoms is classified as “fatigue eyes”, which is a kind of syndrome.

この様な目のトラブルの内、特に近年その対応が必要とされているのは、前述の如く、疲れ目であって、その回復に時間を要する、比較的重篤なものである。これは、この様な症状が近年急増している状況と、その根本的な原因が不明であるためである。この為、この様な疲れ目に対する対応は、充分に目の休養をすることと、ビタミン類などを含有する目薬の投与で姑息な対応しか存しないと言える。この様な状況に鑑み、本発明者らは、スイカズラ科スイカズラ属ハスカップの抽出物に、この様な疲れ目の予防と改善効果が存することを見いだした(例えば、特許文献1)。しかしながら、更に詳細に検討を加えると、ハスカップの採取時期、産地などによって、かかる効果のばらつきが少なくないことを見いだした。即ち、この有用な疲れ目改善素材の効果を安定して維持して行く技術の開発が望まれていた。   Among such eye troubles, in particular, it has been necessary to deal with these problems in recent years because, as described above, the eyes are tired and require a long time to recover. This is because such symptoms have increased rapidly in recent years and the underlying cause is unknown. For this reason, it can be said that there is only a palliative response to such fatigued eyes by sufficiently resting the eyes and administering eye drops containing vitamins and the like. In view of such a situation, the present inventors have found that an extract of a honeysuckle family honeysuckle genus lotus cup has such a fatigue eye prevention and improvement effect (for example, Patent Document 1). However, when further examination was made, it was found that there were many variations in the effect depending on the collection time of the Hascup and the production area. That is, it has been desired to develop a technique for stably maintaining the effect of this useful material for improving fatigue eyes.

一方、疲れ目に対して好ましい作用を発現する成分としては、ブルーベリー中のアントシアニンが知られている(例えば、特許文献2を参照)が、ハスカップ中に含まれるアントシアニン量は、その効果ほどは多くはないし、効果のばらつきとアントシアニン量の関係も不明瞭であった。   On the other hand, an anthocyanin in blueberries is known as a component that exhibits a favorable action on fatigue eyes (see, for example, Patent Document 2), but the amount of anthocyanin contained in a lotus cup is as large as its effect. The relationship between the variation in effect and the amount of anthocyanin was also unclear.

他方、ベリー類にはアントシアニン以外にシアニジン配糖体が含有されていることは既に知られている(例えば、特許文献3を参照)。又、かかるシアニジン配糖体には抗肥満作用、抗糖尿病作用、抗腫瘍作用が存することも既に知られており、これが非常に強い抗酸化活性によるものであることが報告されている(例えば、特許文献4、特許文献5を参照)。シアニジン−3−O−グルコシドやシアニジン−3−O−ルチノシドがロドプシンの再合成を刺激することも知られている(例えば、非特許文献5を参照)。しかしながら、かかる成分がハスカップ抽出物の疲れ目の改善、予防の活性本体であることは全く知られていないし、かかる成分の量をコントロールすることにより、ハスカップの抽出物の疲れ目の改善・予防効果のばらつきを抑えられることも全く知られていない。   On the other hand, it is already known that berries contain cyanidin glycosides in addition to anthocyanins (see, for example, Patent Document 3). Moreover, it is already known that such cyanidin glycosides have an anti-obesity action, an anti-diabetic action, and an anti-tumor action, and it has been reported that this is due to a very strong antioxidant activity (for example, (See Patent Document 4 and Patent Document 5). It is also known that cyanidin-3-O-glucoside and cyanidin-3-O-rutinoside stimulate rhodopsin resynthesis (see, for example, Non-Patent Document 5). However, it is not known at all that this component is an active body for the improvement and prevention of fatigue eye of the Hascup extract, and by controlling the amount of such component, the effect of improving and preventing the fatigue eye of the Hascup extract It is not known at all that it is possible to suppress the variation of.

特開2007−089450号公報JP 2007-089450 A 特開2001−224320号公報JP 2001-224320 A WO2002/022847WO2002 / 022847 特開2003−252766号公報JP 2003-252766 A 特開2000−178295号公報JP 2000-178295 A 渥美一成 「調節・眼精疲労」、第5−6頁、講談社、2001年Kazunari Atsumi, “Adjustment / eye strain”, 5-6, Kodansha, 2001 井上正康ら、「疲労の科学」、第17−26頁、金原出版、1999年Inoue Masayasu et al., "Fatigue Science", pp. 17-26, Kanehara Publishing, 1999 Zigman.S Photochem Photobiol. 57(6) , 1060-1068(1993)Zigman.S Photochem Photobiol. 57 (6), 1060-1068 (1993) J.CEJKOVA et al. Physiol.Res. 53 , 1-10(2004)J.CEJKOVA et al. Physiol.Res. 53, 1-10 (2004) Matsumoto H. et.al. ,J Agric Food Chem. 2003 ;51(12):3560-3.Matsumoto H. et.al., J Agric Food Chem. 2003; 51 (12): 3560-3.

本発明は、この様な状況下為されたものであり、有用な疲れ目改善素材の効果を安定して維持して行く技術を提供することを課題とする。   The present invention has been made under such circumstances, and an object of the present invention is to provide a technique for stably maintaining the effect of a useful fatigue eye improving material.

この様な状況に鑑みて、本発明者らは、有用な疲れ目改善素材の効果を安定して維持して行く技術を求めて、鋭意研究努力を重ねた結果、シアニジン−3−O−配糖体がこの様な作用の有効成分であり、かかる成分が一日あたりの摂取量が1〜1000mgになるように、前記疲れ目改善素材を含有する食品を製剤設計することにより、この様な維持が為しうることを見いだし、発明を完成させた。即ち、本発明は以下に示すとおりである。
(1)シアニジン−3−O−配糖体を有効成分として含有する疲れ目の改善又は予防用の食品であって、該シアニジン−3−O−配糖体の一日あたりの摂取量が1〜1000mgであることを特徴とする、食品。
(2)前記シアニジン−3−O−配糖体として、シアニジン−3−O−グルコシドと、シアニジン−3−O−ルチノシドとをともに含有することを特徴とする、(1)に記載の食品。
(3)前記シアニジン−3−O−ルチノシドの含有量が、シアニジン−3−O−グルコシドの含有量の1〜10質量%であることを特徴とする、(2)に記載の食品。
(4)前記シアニジン−3−O−配糖体の基源が、スイカズラ科スイカズラ属に属するハスカップ(Lonicera caerulea L.)の果実の抽出物であることを特徴とする、(1)〜(3)何れかに記載の食品。
(5)前記スイカズラ科スイカズラ属に属するハスカップ(Lonicera caerulea L.)は中華人民共和国産のものであることを特徴とする、(4)に記載の食品。
(6)スイカズラ科スイカズラ属に属するハスカップ(Lonicera caerulea L.)の果実の抽出物を含有する、疲れ目の予防又は改善用の食品であって、前記スイカズラ科スイカズラ属に属するハスカップ(Lonicera caerulea L.)の果実の抽出物における、シアニジン−3−O−配糖体の含有量が3〜30質量%であることを特徴とする、食品。
(7)前記シアニジン−3−O−配糖体として、シアニジン−3−O−グルコシドと、シアニジン−3−O−ルチノシドとをともに含有することを特徴とする、(6)に記載の食品。
(8)スイカズラ科スイカズラ属に属するハスカップ(Lonicera caerulea L.)の果実の抽出物を濃縮し、該濃縮物中のシアニジン−3−O−グルコシドと、シアニジン−3−O−ルチノシドとを定量し、両者を含み、且つ、濃縮物総量に対するシアニジン−3−O−配糖体の含有量が3〜30質量%であることを確認し、これを配合することを特徴とする、疲れ目の予防又は改善用の食品の製造法。
In view of such a situation, the present inventors have sought for a technique for stably maintaining the effect of a useful fatigue eye improving material, and as a result of intensive research efforts, as a result, cyanidin-3-O-alcohol has been obtained. By designing the food containing the fatigue eye ameliorating material so that the sugar is an active ingredient having such an action and the daily intake of the ingredient is 1-1000 mg, I found that it could be maintained and completed the invention. That is, the present invention is as follows.
(1) A food for improving or preventing fatigue eyes containing cyanidin-3-O-glycoside as an active ingredient, wherein the daily intake of the cyanidin-3-O-glycoside is 1 A food product characterized by being -1000 mg.
(2) The food according to (1), wherein the cyanidin-3-O-glycoside contains both cyanidin-3-O-glucoside and cyanidin-3-O-rutinoside.
(3) The food according to (2), wherein the content of cyanidin-3-O-rutinoside is 1 to 10% by mass of the content of cyanidin-3-O-glucoside.
(4) The base source of the cyanidin-3-O-glycoside is an extract of a fruit of a lotus cup (Lonicera caerulea L.) belonging to the genus Honeysuckle family Lonicera caerulea L. (1) to (3 food of any crab described).
(5) The food according to (4) , characterized in that the lotus cup (Lonicera caerulea L.) belonging to the genus Honeysuckle family is from the People's Republic of China.
(6) A food for preventing or ameliorating fatigue eyes, which contains an extract of a lotus fruit (Lonicera caerulea L.) fruit that belongs to the honeysuckle family Lonicera caerulea L. .) Food extract, wherein the content of cyanidin-3-O-glycoside in the fruit extract is 3 to 30% by mass.
(7) The food according to (6), wherein the cyanidin-3-O-glycoside contains both cyanidin-3-O-glucoside and cyanidin-3-O-rutinoside.
(8) Concentrating an extract of a lotus fruit (Lonicera caerulea L.) fruit belonging to the genus Honeysuckle family, and quantifying cyanidin-3-O-glucoside and cyanidin-3-O-lutinoside in the concentrate. In addition, it is confirmed that the content of cyanidin-3-O-glycoside is 3 to 30% by mass with respect to the total amount of the concentrate, and this is blended to prevent fatigue eyes. Or the manufacturing method of the food for improvement.

本発明によれば、有用な疲れ目改善素材の効果を安定して維持して行く技術を提供することができる。   ADVANTAGE OF THE INVENTION According to this invention, the technique which maintains stably the effect of a useful fatigue eye improvement raw material can be provided.

本発明の食品は、疲れ目の改善又は予防用の食品であって、シアニジン−3−O−配糖体を有効成分として含有し、該シアニジン−3−O−配糖体の一日あたりの摂取量が1〜1000mgであることを特徴とする。通常この様な疲れ目の改善又は予防用の食品は、ツツジ科スノキ属の植物の果実であるブルーベリーなどのビルベリー類の抽出物を含有するものが知られている。これはビルベリー類の果実にはアントシアニンの含有量が多く、かかるアントシアニンがロドプシンの再合成に好ましい作用を発揮すると考えられているためである。しかしながら、本発明者の検討では、後記実施例に示す如く、アントシアニンの含有量はビルベリー類と同程度であっても、ハスカップ(スイカズラ科スイカズラ属クロミノウグイスカグラおよびケヨノミ)の果実の抽出物において、ビルベリーを上回る疲れ目の改善・予防効果が認められた。これはアントシアニン量のみでは疲れ目の改善・予防効果が説明しきれないことを意味する。この知見をもとに本発明者らはビルベリーとハスカップの果実の抽出物の含有成分の比較を行った。尚、本発明において、ハスカップとは、Lonicera caerulea L. ssp. edulis HultenまたはLonicera caerulea L. ssp. edulis Hulten var. emphyllocalyx Nakaiの果実を総称するものであり、これらの中ではLonicera caerulea L. ssp. edulis Hultenの果実が特に好ましい。   The food of the present invention is a food for improving or preventing fatigue eyes, containing cyanidin-3-O-glycoside as an active ingredient, and the cyanidin-3-O-glycoside per day The intake is 1-1000 mg. Usually, such foods for improving or preventing fatigue eyes are known to contain an extract of bilberries such as blueberries, which are fruits of a plant belonging to the genus Vaccinaceae. This is because the fruit of bilberries has a high content of anthocyanins, and it is considered that such anthocyanins exert a favorable action on the resynthesis of rhodopsin. However, in the study of the present inventor, as shown in the examples below, even when the anthocyanin content is similar to that of bilberries, in the fruit extract of the lotus cups The improvement and prevention effects of fatigued eyes over bilberries were observed. This means that the amount of anthocyanin alone cannot explain the effect of improving and preventing fatigue eyes. Based on this finding, the present inventors compared the components contained in the fruit extract of bilberry and lotus cup. In the present invention, the lotus cup is a generic term for the fruits of Lonicera caerulea L. ssp. Edulis Hulten or Lonicera caerulea L. ssp. Edulis Hulten var. Emphyllocalyx Nakai. The fruit of edulis Hulten is particularly preferred.

<比較試験例>
以下に示す手順に従って、ビルベリーとハスカップの抽出物の含有成分の比較を行った。ハスカップについては、北海道産のものと、中国黒竜江省産のものを用い、ビルベリーとしては、フィンランド産のものを用いた。果実100gを擂壊し、超音波を30分間照
射し、遠心分離(2000rpm、20分)し、果汁を取り出し、残渣に1%塩酸加50%メタノール水溶液50mlを加え、超音波を30分間照射し、遠心分離(2000rpm、20分)し、上清を果汁と合わせ、1%塩酸加50%メタノール水溶液を加えて100mlにメスアップし、0.45μmの「ミリポア」フィルターで濾過し検体とした。これをHPLCを用いて、次に示す条件でアントシアニン総量、シアニジン−3−−グルコシド(以下、C3Gと略することもある。)量、シアニジン−3−O−ノシド(以下、C3Rと略することもある。)量を絶対検量線法にて定量した。結果を図1に示す。ハスカップとビルベリーはアントシアニンの総含有量については殆ど同じであったが、C3G、C3Rについては、ハスカップの方が有意に多かった。又、ハスカップにおいても北海道産と中国黒竜江省産では有意差が存した。又、後記に示す効果の差より、疲れ目にはアントシアニン総量よりも、C3GやC3Rと言ったシアニジン配糖体含有量により、疲れ目の改善・予防効果は律せられることがわかる。この意味でアントシアニンの内シアニジン配糖体の含有量の多い、ハスカップ、取り分け中国産のハスカップは疲れ目の改善・予防用の有効成分の基源として好ましいことが分かる。
(HPLC条件)カラム;Develosil RPAQUEOUS(C-30,i.d. 4.6×250mm)(Nomura Chemical Co. Ltd)、検出器:PDA検出器 520nm、流速;1mL/min、カラム温度;40℃、移動相;0.05%リン酸・8%CH 3 CN:0.05%リン酸・30%CH 3 CN=100:0→0:100(リニアグラージェント)
<Comparative test example>
In accordance with the procedure shown below, the components contained in the extract of bilberry and hascup were compared. The lotus cups from Hokkaido and Heilongjiang, China were used, and the bilberries from Finland were used. Crush 100 g of fruit, irradiate with ultrasonic waves for 30 minutes, centrifuge (2000 rpm, 20 minutes), take out the fruit juice, add 50 ml of 1% hydrochloric acid and 50% aqueous methanol solution to the residue, irradiate with ultrasonic waves for 30 minutes, Centrifugation (2000 rpm, 20 minutes), the supernatant was combined with fruit juice, 1% hydrochloric acid-added 50% methanol aqueous solution was added to make up to 100 ml, and the mixture was filtered through a 0.45 μm “Millipore” filter. Which using HPLC, anthocyanin total under the following conditions, cyanidin-3-O - glucoside (. Hereinafter, sometimes abbreviated as C3G) amount, cyanidin-3-O-Le Chi Noshido (hereinafter, the C3R The amount was quantified by the absolute calibration curve method. The results are shown in FIG. Hascup and bilberry were almost the same in terms of the total content of anthocyanins, but C3G and C3R were significantly more in Hascup. In addition, significant differences also in Hokkaido and China Heilongjiang production in Lonicera caerulea has exist. From the difference in effects shown below, it can be seen that, in fatigue, the effect of improving and preventing fatigue is regulated by the content of cyanidin glycosides such as C3G and C3R rather than the total amount of anthocyanins. In this sense, it can be seen that a lotus cup of anthocyanins with a high cyanidin glycoside content, especially a lotus cup made in China is preferable as a base of an active ingredient for improving and preventing fatigue eyes.
(HPLC conditions) Column: Develosil RPAQUEOUS (C-30, id 4.6 × 250 mm) (Nomura Chemical Co. Ltd), detector: PDA detector 520 nm, flow rate: 1 mL / min, column temperature: 40 ° C., mobile phase: 0.05 % Phosphoric acid, 8% CH 3 CN: 0.05% phosphoric acid, 30% CH 3 CN = 100: 0 → 0: 100 (linear gradient)

斯くの如くに、疲れ目の改善・予防作用については、その効果の大小がシアニジン配糖体の含有量によって、説明されることが分かる。即ち、ハスカップやビルベリー中のシアニジン配糖体の量を定量し、この量が一定になるように製剤的な調整を行うことにより、常に安定した効果の食品を提供することが出来る。この様な調整方法としては、原料となるハスカップの果実の抽出物の濃縮物のシアニジン配糖体を計測し、予め、シアニジン配糖体の含有量の多い抽出物と、シアニジン配糖体の含有量の少ない抽出物とを用意し、これらを測定結果に照らして、適宜混合して、シアニジン配糖体の含有量を調整することが好ましく例示できる。   Thus, it can be seen that the effect of improving and preventing fatigue is explained by the content of cyanidin glycoside. That is, the amount of cyanidin glycoside in the lotus cup or bilberry is quantified, and the preparation is adjusted so that the amount is constant, thereby providing a food with a stable effect at all times. As such an adjustment method, the cyanidin glycoside of the concentrate of the extract of the fruit of the cup as a raw material is measured, and the extract containing a large amount of cyanidin glycoside and the inclusion of the cyanidin glycoside in advance It can preferably be exemplified by preparing an extract with a small amount and mixing them appropriately in light of the measurement results to adjust the content of cyanidin glycoside.

この様なシアニジン配糖体を含むハスカップの果実抽出物における、前記シアニジン配糖体の含有量の調整は、製剤において、一日あたりの摂取量が1〜1000mgである様に調整することが好ましく、より好ましくは、2〜500mg、さらに好ましくは3〜100mgになるように調整することが例示できる。この様な条件を達成するには、シアニジン−3−O−配糖体の含有量が3〜30質量%、より好ましくは5〜25質量%である、ハスカップの抽出物の濃縮物を、10〜50質量%製剤に含有させることが例示できる。かかる製剤を適宜1回乃至は数回に分けて摂取し、前記の量範囲のシアニジン配糖体を摂取することが好ましい。この様な製剤の剤形化に際しては、通常食品で使用される任意成分をともに含有せしめることが出来る。この様な任意成分としては、例えば、乳糖や還元麦芽糖などの糖類、アラビアゴムやキサンタンゴムなどの結合剤、結晶セルロースやデンプンなどの崩壊剤、ゼインやシェラックのような被覆剤、矯味矯臭剤、分散剤、乳化剤、糖衣剤などが好適に例示できる。前記必須成分と前記任意成分とを常法に従って処理することにより、本発明の食品は、食品として知られている剤形であれば特段の限定無く適用することが出来、例えば、錠剤、散剤、粉末ジュースを包含する顆粒剤等に加工することが出来る。
The content of the cyanidin glycoside in the fruit extract of a lotus cup containing such a cyanidin glycoside is preferably adjusted so that the daily intake in the preparation is 1-1000 mg. More preferably, it can be adjusted to 2 to 500 mg, more preferably 3 to 100 mg. In order to achieve such conditions, a concentrate of a Hascup extract having a cyanidin-3-O-glycoside content of 3 to 30% by mass, more preferably 5 to 25% by mass, It can be exemplified to be contained in a preparation of ˜50 mass%. To appropriately once such preparations taken several times, it is preferable to ingest cyanidin glycosides of said range of amount. In formulating such a preparation, it is possible to contain any optional ingredients that are usually used in foods. Examples of such optional components include sugars such as lactose and reduced maltose, binders such as gum arabic and xanthan gum, disintegrants such as crystalline cellulose and starch, coating agents such as zein and shellac, flavoring agents, A dispersing agent, an emulsifier, a sugar coating agent, etc. can be illustrated suitably. By treating the essential component and the optional component according to a conventional method, the food of the present invention can be applied without particular limitation as long as it is a dosage form known as food, for example, tablets, powders, It can be processed into granules including powdered juice.

以下に実施例を挙げて、更に詳細に本発明について説明を加えるが、本発明がかかる実施例にのみ限定されないことは言うまでもない。   Hereinafter, the present invention will be described in more detail with reference to examples, but it goes without saying that the present invention is not limited to such examples.

<製造例1>
比較試験例で用いた中国黒竜江省産のハスカップの果実100gを擂して、これに50%エタノール水溶液200mlを加え、超音波を10分間照射し、遠心分離(1000
rpm×10分)を行い、上清を得た。上清を減圧濃縮した後、凍結乾燥に付し、12.5gのアモルファスを得た。このものを前記のHPLC条件で分析し、シアニジン配糖体の含有量を求めたところ、C3Gを3.2質量%、C3Rを0.1質量%含有していた。又、総アントシアニン量は3.4%であった。
<Production Example 1>
And ulcers to fruit 100g of Lonicera caerulea China Heilongjiang production used in Comparative Test Examples, to which 50% aqueous ethanol 200ml was added, ultrasound was irradiated for 10 min, centrifuged (1000
rpm × 10 minutes) to obtain a supernatant. The supernatant was concentrated under reduced pressure and then freeze-dried to obtain 12.5 g of amorphous. This was analyzed under the above-mentioned HPLC conditions, and the content of cyanidin glycoside was determined. As a result, it contained 3.2% by mass of C3G and 0.1% by mass of C3R. The total amount of anthocyanins was 3.4%.

<製造例2>
製造例1のハスカップの果実をフィンランド産のビルベリーの果実に置き換えて、同様の操作を行い13.3gのアモルファスを得た。シアニジン配糖体の含有量を求めたところ、C3Gを0.3質量%含有していた。C3Rについては存在を認めなかった。又、総アントシアニン量は3.1%であった。
<Production Example 2>
The fruit of the lotus cup of Production Example 1 was replaced with the fruit of Finnish bilberry, and the same operation was performed to obtain 13.3 g of amorphous. When the content of the cyanidin glycoside was determined, it contained 0.3% by mass of C3G. The presence of C3R was not recognized. The total amount of anthocyanins was 3.1%.

<製造例3>
下記処方に従って、本発明の食品1(錠剤)を製造した。即ち、処方成分をニューマルメライザー(不二パウダル株式会社製)に仕込み、50質量部の水を噴霧しながら、40℃の温風を送り、流転動相造粒を行った。造粒後更に2時間40℃の温風を送風し、乾燥させ、出来た顆粒を打錠して、200mgのチューナブルタブレットを得た。
<Production Example 3>
The food 1 (tablet) of the present invention was produced according to the following formulation. That is, the prescription components were charged into a pneumomerizer (manufactured by Fuji Powder Co., Ltd.), and while spraying 50 parts by mass of water, warm air at 40 ° C. was fed to perform flow rolling granulation. After granulation, warm air of 40 ° C. was further blown for 2 hours and dried, and the resulting granule was tableted to obtain a 200 mg tunable tablet.

Figure 0004848315
Figure 0004848315

<製造例4>
製造例3の食品1の製造例1のアモルファスを製造例2のアモルファスに置換して、同様に処置し、比較例1のチューナブルタブレットを得た。
<Production Example 4>
The amorphous product of Production Example 1 of Production Example 3 was replaced with the amorphous product of Production Example 2 and treated in the same manner to obtain a tunable tablet of Comparative Example 1.

<飲用試験>
製造例3の食品1と製造例4の比較例1について、1群15名の疲れ目のパネラー30名(2群)での飲用試験を行った。飲用期間は2ヶ月で、連日朝、昼、晩の3回6錠づつ錠剤を摂取してもらった。食品1の群では1日あたり59.4mgのシアニジン配糖体を、比較例1の群では5.4mgのシアニジン配糖体を摂取することになる。試験の前後に、目元のサーモグラフィー、フリッカーテスト、近点位置、暗順応を計測し、飲用による変化を見た。結果を図2(フリッカーテスト)、図3(近点位置)、図4(暗順応)に示す。これより、食品1は有意に比較例1よりも、疲れ目の改善・予防作用に優れることが分かる。即ち、アントシアニン類の内、シアニジン配糖体が疲れ目の改善・予防に大きな寄与をしていることが分かる。シアニジン配糖体の量をコントロールすることにより、疲れ目の改善・予防作用を制御できることが分かる。

具体的な測定手順は以下に示す。
(1)サーモグラフィー
測定機器:日本アビオニクス株式会社 Neo Thermo TVS−700
測定環境:室温25±2℃、湿度50±15%
手順:恒温恒湿の部屋に入室後10分間の馴化を行い、サーモグラフィーの撮影を行った。
(2)フリッカーテスト
測定機器:柴田科学株式会社 学研デジタルフリッカー値測定器 RDF−1
測定環境:特に指定なし(実際はサーモ撮影と同じ部屋で実施)
手順:サーモグラフィーと同様に馴化後、フリッカー値測定 5回/セット×3セットを測定(はじめの1セットは暗順応として実際には2から3セットの値を解析)
(3)近点位置
測定機器:浜松ホトニクス株式会社 近見反応測定装置 TriIRIS C9000
測定環境:特に指定なし(実際はサーモ撮影と同じ部屋で実施)
測定手順:サーモグラフィーと同様に馴化後、5回測定
(4)暗順応
測定機器:とくになし
測定環境:一定光量下の部屋
測定手順:入室後20分間馴化し、消灯後、30cmほど離れたところにある視力検診用の標準指標であるランドル環を認識する時間を測定した。
<Drinking test>
About the foodstuff 1 of the manufacture example 3, and the comparative example 1 of the manufacture example 4, the drinking test by the panelist 30 persons (2 groups) of 15 eyes per group was done. The drinking period was 2 months, and 6 tablets were taken 3 times a day in the morning, noon and evening. The food 1 group will receive 59.4 mg of cyanidin glycoside per day, and the group of Comparative Example 1 will receive 5.4 mg of cyanidin glycoside. Before and after the test, eye thermography, flicker test, near point position, dark adaptation were measured, and changes due to drinking were observed. The results are shown in FIG. 2 (flicker test), FIG. 3 (near point position), and FIG. 4 (dark adaptation). From this, it can be seen that food 1 is significantly superior to Comparative Example 1 in improving and preventing fatigue eyes. That is, it can be seen that among the anthocyanins, cyanidin glycosides greatly contribute to the improvement and prevention of fatigue eyes. It can be seen that by controlling the amount of cyanidin glycoside, the improvement / prevention of fatigue eyes can be controlled.

The specific measurement procedure is shown below.
(1) Thermographic measuring instrument: Nippon Avionics Co., Ltd. Neo Thermo TVS-700
Measurement environment: room temperature 25 ± 2 ℃, humidity 50 ± 15%
Procedure: Acclimatization was performed for 10 minutes after entering a room of constant temperature and humidity, and thermography was taken.
(2) Flicker test measuring instrument: Shibata Science Co., Ltd. Gakken digital flicker value measuring instrument RDF-1
Measurement environment: Not specified (actually performed in the same room as the thermography)
Procedure: After acclimatization like thermography, flicker value measurement 5 times / set x 3 sets are measured (the first 1 set is actually dark adaptation and 2 to 3 sets are actually analyzed)
(3) Near-point position measuring instrument: Hamamatsu Photonics Co., Ltd. Kimimi reaction measuring device TriIRIS C9000
Measurement environment: Not specified (actually performed in the same room as the thermography)
Measurement procedure: After acclimatization similar to thermography, measured 5 times (4) Dark adaptation Measuring instrument: None Measurement environment: Room measurement under constant light intensity Procedure: Acclimatization for 20 minutes after entering the room, after turning off, about 30 cm away The time to recognize the Randle ring, which is a standard index for visual acuity screening, was measured.

本発明は、健康食品などの食品に応用できる。   The present invention can be applied to foods such as health foods.

果実毎のアントシアニンの含有パターンを示す図である。It is a figure which shows the content pattern of the anthocyanin for every fruit. 実施例1の飲用試験の結果を示す図である。It is a figure which shows the result of the drinking test of Example 1. 実施例1の飲用試験の結果を示す図である。It is a figure which shows the result of the drinking test of Example 1. 実施例1の飲用試験の結果を示す図である。It is a figure which shows the result of the drinking test of Example 1.

Claims (1)

スイカズラ科スイカズラ属に属するハスカップ(Lonicera caerulea L.)の果実の抽出物を濃縮し、縮物中シアニジン−3−O−グルコシドと、シアニジン−3−O−ルチノシド含み、シアニジン−3−O−ルチノシドの含有量が、シアニジン−3−O−グルコシドの含有量の1〜10質量%であり、且つ、濃縮物総量に対するシアニジン−3−O−配糖体の含有量が3〜30質量%であるように調整し、配合することを特徴とする、疲れ目の予防又は改善用の食品の製造法。 Concentrated fruit extract of Caprifoliaceae honeysuckle belonging Lonicera caerulea (Lonicera caerulea L.), and cyanidin -3-O-glucoside in concentrated Chijimibutsu include cyanidin -3-O-rutinoside, cyanidin-3- The content of O-rutinoside is 1 to 10% by mass of the content of cyanidin-3-O-glucoside, and the content of cyanidin-3-O-glycoside with respect to the total concentrate is 3 to 30% by mass. The method for producing a food for preventing or ameliorating fatigue eyes , comprising adjusting and blending the composition so as to be %.
JP2007151072A 2007-06-07 2007-06-07 Fatigue food and its manufacturing method Active JP4848315B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007151072A JP4848315B2 (en) 2007-06-07 2007-06-07 Fatigue food and its manufacturing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007151072A JP4848315B2 (en) 2007-06-07 2007-06-07 Fatigue food and its manufacturing method

Publications (3)

Publication Number Publication Date
JP2008301752A JP2008301752A (en) 2008-12-18
JP2008301752A5 JP2008301752A5 (en) 2010-08-05
JP4848315B2 true JP4848315B2 (en) 2011-12-28

Family

ID=40231024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007151072A Active JP4848315B2 (en) 2007-06-07 2007-06-07 Fatigue food and its manufacturing method

Country Status (1)

Country Link
JP (1) JP4848315B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019059691A (en) * 2017-09-27 2019-04-18 オリザ油化株式会社 Eye fatigue improver and stiff shoulder improver

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1208755B1 (en) * 1999-07-02 2008-03-12 Meiji Seika Kaisha Ltd. Compositions for foods, process for producing the same and functional foods and drinks containing the same
JP2005117910A (en) * 2003-10-14 2005-05-12 Tokiwa Shokubutsu Kagaku Kenkyusho:Kk Method for producing cassis extract
JP4247833B2 (en) * 2004-03-16 2009-04-02 株式会社ケーツーコミュニケーションズ Visual function improver
JP2006083149A (en) * 2004-09-17 2006-03-30 Shonan Institute For Medical & Preventive Science Agent and food for inhibiting cyclooxygenase and inducible nitrogen monoxide synthase
JP2006304761A (en) * 2005-05-02 2006-11-09 Kazuo Sakuma Lonicera caerulea l. product containing component inhibiting vancomycin-resisting enterococcus (vre), methicillin resistant staphylococcus aureus (mrsa)
JP4873904B2 (en) * 2005-08-22 2012-02-08 国立大学法人弘前大学 Ocular blood flow disorder improving agent
JP2007089450A (en) * 2005-09-28 2007-04-12 Pola Chem Ind Inc Food for controlling eyestrain
JP2008115144A (en) * 2006-11-06 2008-05-22 Yoneyama Mototsune Manufacturing method of dense polyphenol from lonicera caerulea liquid

Also Published As

Publication number Publication date
JP2008301752A (en) 2008-12-18

Similar Documents

Publication Publication Date Title
JP6265500B2 (en) Dry eye prevention and treatment
AU2015256995B2 (en) Fat or oil extract of black ginger and method for producing same
JP6076335B2 (en) Pharmaceutical composition for inhibiting histamine receptor activity and food composition for preventing or improving sleep disorder, anxiety or depression
US20220151276A1 (en) Composition containing plant-derived extract and/or plant-derived processed product
KR101614929B1 (en) A pharmaceutical composition for treating cognitive and memory impairment
JP4848315B2 (en) Fatigue food and its manufacturing method
JPWO2019065396A1 (en) Production method of purified Salacia plant extract and purified Salacia plant extract
KR20120132653A (en) Novel use of rice bran extract or rice bran powder for improving, preventing or treating sleep disorders, anxiety, or depression
KR20210091989A (en) COMPOSITION FOR ANTI-OXIDATION OR ANTI-INFLAMMATION COMPRISING Helianthus tuberosus AND Liriope platyphylla AS AN EFFECTIVE INGREDIENT AND METHOD FOR PREPARING THE SAME
US20230020109A1 (en) Pharmaceutical composition for alleviating eye fatigue, containing, as active ingredients, luteolin-7-o-diglucuronide and apigenin-7-o-diglucuronide isolated from perilla frutescens (l.) britton var. acuta (thunb.) kudo leaf extract
KR101453455B1 (en) Pharmaceutical composition or healthy food composition containing Oenanthe javanica extract, fractions thereof or isolated flavonoidic compounds for antioxidant and antiobesity activity
KR20210056771A (en) A composition for reinforcing immune function comprising the extract of oat sprout
KR20170053536A (en) Beverages for preventing respiratory disease and hyperlipidemia containing Platycodon grandiflorum and its preparing method
JP2008301752A5 (en)
JPH0759539A (en) Alpha-amylase inhibitory matter
KR20200069077A (en) Composition for preventing, ameliorating or treating atopic dermatitis comprising Apium graveolens hydrolysate as effective component
KR101484705B1 (en) Method for processing Sorghum bicolor with high biological activity and product using the same
JP6998212B2 (en) A β-secretase inhibitor containing turmeron as an active ingredient, and foods and drinks containing the inhibitor.
KR102588130B1 (en) Composition for preventing or treating inflammatory raspiratory diseases caused by ultrafine dust containing mugwort and lizard’s tail extract as an active ingredient
KR100887234B1 (en) Composition for preventing or improving diabetes induced complication containing phellinus baumii extract
JP7095872B2 (en) Interleukin-33 production inhibitor and pharmaceuticals, quasi-drugs, cosmetics and food and drink compositions for the prevention, treatment or suppression of allergic diseases associated with an increase in interleukin-33.
KR20160088840A (en) Composition for prevention or treatment of glutamate toxicity related diseases containing butyrolatone derivatives or pharmaceutically acceptable salts thereof as an active ingredient
KR101961560B1 (en) Composition for improving, prevention or treatment of muscular atrophy comprising Solanum tuberosum L. extract
KR101990199B1 (en) Pharmaceutical composition for the prevention or treatment of tuberculosis comprising 3,6-dihydroxyflavone or pharmaceutically acceptable salts thereof as an active ingredient
JP2020125327A (en) β-SECRETASE INHIBITOR CONTAINING TURMERONE AS ACTIVE INGREDIENT, AND PHARMACEUTICAL PREPARATION AND FOOD/DRINK CONTAINING SAID INHIBITOR

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100421

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100421

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20100421

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100524

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110524

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110729

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110927

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111017

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141021

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4848315

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250